Active	Status	Sponsor type	Region	Phase	Filter
3 Active 13 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mody, Sheila
ABC for D&E, NCT04254081: Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion	Completed	4	57	US	Buprenorphine 0.15 MG, Lidocaine 1% Injectable Solution	University of California, San Diego, Society of Family Planning	Procedural Pain, Buprenorphine, Adjuvants, Anesthesia, Dilation and Evacuation, Analgesics	05/21	05/21
NCT03736681: Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage	Active, not recruiting	1	113	US	40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block, 20cc 1% lidocaine with 2 units of vasopressin paracervical block	University of California, San Diego, University of California, Los Angeles	Abortion Early, Abortion, Missed, Abortion, Spontaneous, Abortion in First Trimester	12/20	07/21
CALM, NCT04725643: Keep Contraceptive Arm Long Acting-iMplant () and Carry On	Active, not recruiting	N/A	55	US	Track bleeding patterns before and after implant	University of California, San Diego, Merck Sharp & Dohme LLC	Contraception, Contraceptive Usage, Family Planning	01/24	12/24
Pak, Janie
No trials found